Skip to main content
. 2023 Jan 18;314:114678. doi: 10.1016/j.jviromet.2023.114678

Table 1.

Results of the high-resolution melting analyses at the N501 site using clinical samples.

Without the addition of the wild-type fragment (conventional HRM-based assay)
HRM result Sanger sequence
N501 (n = 105) N501Y (n = 104)
N501 105 53
N501Y 0 39
Unidentified 0 12
With the addition of the wild-type fragment (modified HRM-based assay)
HRM result Sanger sequence
N501 (n = 105) N501Y (n = 104)
N501 105 10
N501Y 0 78
Unidentified 0 16
Results of the combined assays
N501 (n = 105) N501Y (n = 104)
Both assays positive 105 21
Either assay positive 0 76
Both assays negative 0 7